Details for New Drug Application (NDA): 091671
✉ Email this page to a colleague
The generic ingredient in HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX is chlorpheniramine polistirex; hydrocodone polistirex. There are twenty-nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the chlorpheniramine polistirex; hydrocodone polistirex profile page.
Summary for 091671
Tradename: | HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX |
Applicant: | Neos Theraps Inc |
Ingredient: | chlorpheniramine polistirex; hydrocodone polistirex |
Patents: | 0 |
Pharmacology for NDA: 091671
Mechanism of Action | Histamine H1 Receptor Antagonists Opioid Agonists |
Suppliers and Packaging for NDA: 091671
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX | chlorpheniramine polistirex; hydrocodone polistirex | SUSPENSION, EXTENDED RELEASE;ORAL | 091671 | ANDA | Neos Therapeutics LP | 62542-301 | 62542-301-03 | 70 mL in 1 BOTTLE, GLASS (62542-301-03) |
HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX | chlorpheniramine polistirex; hydrocodone polistirex | SUSPENSION, EXTENDED RELEASE;ORAL | 091671 | ANDA | Neos Therapeutics LP | 62542-301 | 62542-301-04 | 118 mL in 1 BOTTLE, GLASS (62542-301-04) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION, EXTENDED RELEASE;ORAL | Strength | EQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML | ||||
Approval Date: | Jun 29, 2012 | TE: | RLD: | No |
Complete Access Available with Subscription